Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Public Health|January 12, 2018
Change in parental knowledge, attitudes and practice of antibiotic use after a national intervention programmeVerica Ivanovska, Bistra Angelovska, Liset van Dijk, et al.
Drug Safety|March 23, 2011
Today's challenges in pharmacovigilance: what can we learn from epoetins?Hans C Ebbers, Aukje K Mantel-Teeuwisse, Ellen H M Moors, et al.
Obesity (Silver Spring, Md.)|August 23, 2008
Psychiatric and cardiovascular comorbidities in patients with diabetes mellitus starting antiobesity drugsMarjolein J Willemen, Aukje K Mantel-Teeuwisse, Sabine M Straus, et al.
Bulletin of the World Health Organization|August 4, 2009
Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databasesBrenda Waning, Warren Kaplan, Alexis C King, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 31, 2022
Nature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products: A 20-year follow-up study of originators and biosimilarsAli M Alsamil, Thijs J Giezen, Toine C Egberts, et al.
Frontiers in Medicine|March 10, 2018
Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial InfarctionCharlotte Rietbergen, Gudrun Stefansdottir, Hubert G Leufkens, et al.
Drug Discovery Today|April 1, 2022
Four scenarios for the future of medicines and social policy in 2030Hubert G Leufkens, Zuzana Kusynová, Murray Aitken, et al.
European Journal of Clinical Pharmacology|November 5, 2010
Regulatory scientific advice in drug development: does company size make a difference?Michelle Putzeist, Aukje K Mantel-Teeuwisse, Christine C Gispen-De Wied, et al.
Social Science & Medicine (1982)|February 26, 2003
The impact of attitudes and beliefs on length of benzodiazepine use: a study among inexperienced and experienced benzodiazepine usersRolf van Hulten, Arnold B Bakker, Aart C Lodder, et al.
Diabetes Care|January 29, 2011
Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBaseMarjolein J Willemen, Aukje K Mantel-Teeuwisse, Sabine M Straus, et al.
Pageof 4